Cite

HARVARD Citation

    Castellano, D. et al. (2014). Cabazitaxel for metastatic castration-resistant prostate cancer: safety data from the Spanish expanded access program. Expert opinion on drug safety. pp. 1165-1173. [Online]. 
  
Back to record